share_log

Syndax Pharmaceuticals | 8-K: Syndax Reports Third Quarter 2024 Financial Results and Provides Business Update

SEC ·  Nov 5 16:08
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more